Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
JAMA Network Open|February 27, 2024
Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian CancerEmil Lou, Valentino Clemente, Marcel Grube, et al.
Oncotarget|March 19, 2015
Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cellsRachel Isaksson Vogel, Kathleen Coughlin, Alessandra Scotti, et al.
Cancer Research|April 6, 2006
Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosisMartina Bazzaro, Michael K Lee, Alessia Zoso, et al.
Immunology|July 9, 2002
Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8Fabiola Micheletti, Paolo Monini, Cinzia Fortini, et al.
Journal of Visualized Experiments : Jove|February 25, 2014
Method for obtaining primary ovarian cancer cells from solid specimensLee J Pribyl, Kathleen A Coughlin, Thanasak Sueblinvong, et al.
Journal of Cell Science|December 2, 2020
UNC-45A breaks the microtubule lattice independently of its effects on non-muscle myosin IIJuri Habicht, Ashley Mooneyham, Asumi Hoshino, et al.
The American Journal of Pathology|September 18, 2007
Myosin II co-chaperone general cell UNC-45 overexpression is associated with ovarian cancer, rapid proliferation, and motilityMartina Bazzaro, Antonio Santillan, Zhenhua Lin, et al.
European Journal of Immunology|January 5, 2002
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individualsSimona Vertuani, Martina Bazzaro, Guido Gualandi, et al.
Cancer Biology & Therapy|July 23, 2019
UNC-45A is preferentially expressed in epithelial cells and binds to and co-localizes with interphase MTsJuri Habicht, Ashley Mooneyham, Mihir Shetty, et al.
Pageof 5